Division of Nephrology Launches Kidney Stone Prevention Program
David Goldfarb, MD, to lead new unit
Dr. David Goldfarb is pleased to announce the opening of a kidney stone prevention program at NYU, in collaboration with NYU Urology Associates.
Dr. Goldfarb is one of the nation's leaders in the field of medical management and prevention of kidney stones. He is also Clinical Chief of Nephrology at NYULMC and Professor of Medicine and Physiology at the NYU School of Medicine. His current NIH-funded research is part of the Rare Kidney Stone Consortium, for which he is the principal investigator for the study of cystinuria.